Multiple Assemblies exist for SMTL entry 8zmq
Crystal Structure of the second bromodomain of human BRD4 BD2 in complex with the inhibitor Y13190; X-RAY DIFFRACTION 2.20 Å

SMTL ID
8zmq.1
Ligands
2-(2-(adamantan-1-yl)-4-ethyl-1H-imidazol-5-yl)-7-(2-(4-fluoro-2,6-dimethylphenoxy)-5-(2-hydroxypropan-2-yl)phenyl)-5-methylfuro[3,2-c]pyridin-4(5H)-one; DIMETHYL SULFOXIDE
Polypeptides
BRD4_HUMAN
Oligo-state
monomer
SMTL ID
8zmq.2
Ligands
DIMETHYL SULFOXIDE; 2-(2-(adamantan-1-yl)-4-ethyl-1H-imidazol-5-yl)-7-(2-(4-fluoro-2,6-dimethylphenoxy)-5-(2-hydroxypropan-2-yl)phenyl)-5-methylfuro[3,2-c]pyridin-4(5H)-one
Polypeptides
BRD4_HUMAN
Oligo-state
monomer
SMTL ID
8zmq.3
Ligands
2-(2-(adamantan-1-yl)-4-ethyl-1H-imidazol-5-yl)-7-(2-(4-fluoro-2,6-dimethylphenoxy)-5-(2-hydroxypropan-2-yl)phenyl)-5-methylfuro[3,2-c]pyridin-4(5H)-one
Polypeptides
BRD4_HUMAN
Oligo-state
monomer
SMTL ID
8zmq.4
Ligands
2-(2-(adamantan-1-yl)-4-ethyl-1H-imidazol-5-yl)-7-(2-(4-fluoro-2,6-dimethylphenoxy)-5-(2-hydroxypropan-2-yl)phenyl)-5-methylfuro[3,2-c]pyridin-4(5H)-one
Polypeptides
BRD4_HUMAN
Oligo-state
monomer
SMTL ID
8zmq.5
Ligands
2-(2-(adamantan-1-yl)-4-ethyl-1H-imidazol-5-yl)-7-(2-(4-fluoro-2,6-dimethylphenoxy)-5-(2-hydroxypropan-2-yl)phenyl)-5-methylfuro[3,2-c]pyridin-4(5H)-one
Polypeptides
BRD4_HUMAN
Oligo-state
monomer
SMTL ID
8zmq.6
Ligands
2-(2-(adamantan-1-yl)-4-ethyl-1H-imidazol-5-yl)-7-(2-(4-fluoro-2,6-dimethylphenoxy)-5-(2-hydroxypropan-2-yl)phenyl)-5-methylfuro[3,2-c]pyridin-4(5H)-one
Polypeptides
BRD4_HUMAN
Oligo-state
monomer
SMTL ID
8zmq.7
Ligands
2-(2-(adamantan-1-yl)-4-ethyl-1H-imidazol-5-yl)-7-(2-(4-fluoro-2,6-dimethylphenoxy)-5-(2-hydroxypropan-2-yl)phenyl)-5-methylfuro[3,2-c]pyridin-4(5H)-one
Polypeptides
BRD4_HUMAN
Oligo-state
monomer
SMTL ID
8zmq.8
Ligands
2-(2-(adamantan-1-yl)-4-ethyl-1H-imidazol-5-yl)-7-(2-(4-fluoro-2,6-dimethylphenoxy)-5-(2-hydroxypropan-2-yl)phenyl)-5-methylfuro[3,2-c]pyridin-4(5H)-one
Polypeptides
BRD4_HUMAN
Oligo-state
monomer
SMTL ID
8zmq.9
Ligands
2-(2-(adamantan-1-yl)-4-ethyl-1H-imidazol-5-yl)-7-(2-(4-fluoro-2,6-dimethylphenoxy)-5-(2-hydroxypropan-2-yl)phenyl)-5-methylfuro[3,2-c]pyridin-4(5H)-one
Polypeptides
BRD4_HUMAN
Oligo-state
monomer
SMTL ID
8zmq.10
Ligands
2-(2-(adamantan-1-yl)-4-ethyl-1H-imidazol-5-yl)-7-(2-(4-fluoro-2,6-dimethylphenoxy)-5-(2-hydroxypropan-2-yl)phenyl)-5-methylfuro[3,2-c]pyridin-4(5H)-one
Polypeptides
BRD4_HUMAN
Oligo-state
monomer
SMTL ID
8zmq.11
Ligands
2-(2-(adamantan-1-yl)-4-ethyl-1H-imidazol-5-yl)-7-(2-(4-fluoro-2,6-dimethylphenoxy)-5-(2-hydroxypropan-2-yl)phenyl)-5-methylfuro[3,2-c]pyridin-4(5H)-one
Polypeptides
BRD4_HUMAN
Oligo-state
monomer
SMTL ID
8zmq.12
Ligands
2-(2-(adamantan-1-yl)-4-ethyl-1H-imidazol-5-yl)-7-(2-(4-fluoro-2,6-dimethylphenoxy)-5-(2-hydroxypropan-2-yl)phenyl)-5-methylfuro[3,2-c]pyridin-4(5H)-one; GLYCEROL
Polypeptides
BRD4_HUMAN
Oligo-state
monomer
SMTL ID
8zmq.13
Ligands
2-(2-(adamantan-1-yl)-4-ethyl-1H-imidazol-5-yl)-7-(2-(4-fluoro-2,6-dimethylphenoxy)-5-(2-hydroxypropan-2-yl)phenyl)-5-methylfuro[3,2-c]pyridin-4(5H)-one; DIMETHYL SULFOXIDE
Polypeptides
BRD4_HUMAN
Oligo-state
monomer
SMTL ID
8zmq.14
Ligands
2-(2-(adamantan-1-yl)-4-ethyl-1H-imidazol-5-yl)-7-(2-(4-fluoro-2,6-dimethylphenoxy)-5-(2-hydroxypropan-2-yl)phenyl)-5-methylfuro[3,2-c]pyridin-4(5H)-one; DIMETHYL SULFOXIDE
Polypeptides
BRD4_HUMAN
Oligo-state
monomer
SMTL ID
8zmq.15
Ligands
2-(2-(adamantan-1-yl)-4-ethyl-1H-imidazol-5-yl)-7-(2-(4-fluoro-2,6-dimethylphenoxy)-5-(2-hydroxypropan-2-yl)phenyl)-5-methylfuro[3,2-c]pyridin-4(5H)-one
Polypeptides
BRD4_HUMAN
Oligo-state
monomer
SMTL ID
8zmq.16
Ligands
2-(2-(adamantan-1-yl)-4-ethyl-1H-imidazol-5-yl)-7-(2-(4-fluoro-2,6-dimethylphenoxy)-5-(2-hydroxypropan-2-yl)phenyl)-5-methylfuro[3,2-c]pyridin-4(5H)-one
Polypeptides
BRD4_HUMAN
Oligo-state
monomer
SMTL ID
8zmq.17
Ligands
2-(2-(adamantan-1-yl)-4-ethyl-1H-imidazol-5-yl)-7-(2-(4-fluoro-2,6-dimethylphenoxy)-5-(2-hydroxypropan-2-yl)phenyl)-5-methylfuro[3,2-c]pyridin-4(5H)-one
Polypeptides
BRD4_HUMAN
Oligo-state
monomer
SMTL ID
8zmq.18
Ligands
2-(2-(adamantan-1-yl)-4-ethyl-1H-imidazol-5-yl)-7-(2-(4-fluoro-2,6-dimethylphenoxy)-5-(2-hydroxypropan-2-yl)phenyl)-5-methylfuro[3,2-c]pyridin-4(5H)-one
Polypeptides
BRD4_HUMAN
Oligo-state
monomer
SMTL ID
8zmq.19
Ligands
2-(2-(adamantan-1-yl)-4-ethyl-1H-imidazol-5-yl)-7-(2-(4-fluoro-2,6-dimethylphenoxy)-5-(2-hydroxypropan-2-yl)phenyl)-5-methylfuro[3,2-c]pyridin-4(5H)-one
Polypeptides
BRD4_HUMAN
Oligo-state
monomer
SMTL ID
8zmq.20
Ligands
2-(2-(adamantan-1-yl)-4-ethyl-1H-imidazol-5-yl)-7-(2-(4-fluoro-2,6-dimethylphenoxy)-5-(2-hydroxypropan-2-yl)phenyl)-5-methylfuro[3,2-c]pyridin-4(5H)-one
Polypeptides
BRD4_HUMAN
Oligo-state
monomer